Markë tregtare · Shqipëri

MYR Pharmaceuticals (AL/M/1/1591282)

Marka «MYR Pharmaceuticals», në pronësi të MYR GmbH, është depozituar në DPPI më 26.10.2020 për klasat 1, 5, 9, 42 dhe 44; statusi: e regjistruar.

Paraqitja e markës MYR Pharmaceuticals

Përmbledhja e markës

Statusi
E regjistruar
Zyra
Drejtoria e Përgjithshme e Pronësisë Industriale (DPPI)
Nr. i aplikimit
AL/M/1/1591282
Nr. i regjistrimit
AL/M/1/1591282
ID në DPPI
344536
Lloji i markës
E kombinuar
Klasat Nice
1, 5, 9, 42, 44

Datat

Data e depozitimit
26.10.2020
Data e regjistrimit
03.10.2022
Data e skadimit
26.10.2030

Pronari

Emri
MYR GmbH
Adresa
Thomasstr. 10-12 61348 Bad Homburg
Shteti
ALBANIA

Përfaqësuesi

Emri
Gilead Sciences, Inc.
Adresa
Attn: Gretchen R. Stroud, 333 Lakeside Drive Foster City CA 94404 , US

Mallrat dhe shërbimet

Klasa Nice 42 — Teknologji, softuer, kërkim

Scientific and technological services and research and design relating thereto; industrial analysis services; industrial research services; scientific research for medical, chemical, biological, veterinary and pharmaceutical purposes; scientific and technological services and research and design related thereto in the field of hepatitis B; scientific and technological services and research and design related thereto in the field of hepatitis D; scientific and technological services and research and design related thereto in the field of dyslipidemia; scientific and technological services and research and design related thereto in the field of nonalcoholic steatohepatitis [NASH]; scientific and technological services and research and design related thereto in the field of primary biliary cholangitis [PBC]; scientific and technological services and research and design related thereto in the field of inflammatory diseases; scientific and technological services and research and design related thereto in the field of inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services and research and design related thereto in the field of metabolic diseases; scientific and technological services and research and design related thereto in the field of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; design and development of computer hardware and software; scientific and technological services in the field of preclinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], primary biliary cholangitis [PBC], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; scientific and technological services in the field of clinical development, in particular related to hepatitis B, hepatitis D, dyslipidemia, nonalcoholic steatohepatitis [NASH], primary biliary cholangitis [PBC], inflammatory diseases, inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP], metabolic diseases, and metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [MVP]. Class

Klasa Nice 5 — Farmaceutikë

Pharmaceutical and veterinary preparations; biological preparations for medical purposes; biological preparations for veterinary purposes; biochemical preparations for medical purposes; biochemical preparations for veterinary purposes; chemical preparations for medical purposes; chemical preparations for veterinary purposes; medicines for medical purposes; medicines for veterinary purposes; pharmaceutical preparations for treating liver diseases and disorders; pharmaceutical products for hepatitis B; pharmaceutical products for hepatitis D; pharmaceutical preparations for dyslipidemia; pharmaceutical preparations for nonalcoholic steatohepatitis [NASH]; pharmaceutical preparations for primary biliary cholangitis [PBC]; pharmaceutical preparations for inflammatory diseases; pharmaceutical preparations for inflammatory diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]; pharmaceutical preparations for the treatment of metabolic diseases; pharmaceutical preparations for the treatment of metabolic diseases inhibiting sodium-taurocholate co-transporting polypeptide [NTCP]. Class

Klasa Nice 1 — Kimikate

Chemicals for use in industry and science; peptides substrates for scientific and industrial purposes; oligopeptides; polypeptides; proteins [raw material]; polynucleotides [chemicals for scientific purposes]; oligonucleotides [chemicals for scientific purposes]; nucleic acids; SiRNA molecules; small molecules having a molar mass of 160 to 480 [for scientific purposes]. Class

Klasa Nice 9 — Elektronikë, softuer dhe instrumente

Scientific, surveying, weighing, measuring apparatus and instruments; apparatus and instruments for scientific research, in particular scientific research in laboratories; data processing apparatus; computers; CDs; DVDs; digital recording media; computer software. Class

Klasa Nice 44 — Shërbime mjekësore dhe bukurie

Medical services; veterinary services; medical and veterinary services, in particular medical analysis in connection with the treatment of individuals; providing information in the medical field, veterinary field and pharmacology; services of health centres; services of clinics (ambulances); therapy services; hygienic and beauty care for human beings and animals.

Kronologjia

  1. 26.10.2020 — Aplikim i depozituar: Marka u depozitua me numër aplikimi: AL/M/1/1591282
  2. 03.10.2022 — Regjistruar: Marka u regjistrua me numër regjistrimi: AL/M/1/1591282
  3. 26.10.2030 — Data e skadencës / Rinovimi: Marka skadon më 26.10.2030 (1453 ditë)

Të dhëna zyrtare nga Drejtoria e Përgjithshme e Pronësisë Industriale (DPPI). Regjistrimi te zyra

Citimi

«MYR Pharmaceuticals», Markë tregtare AL/M/1/1591282, DPPI (Shqipëri). Trademark.al, https://www.trademark.al/trademarks/public/100565